Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

  • Technology appraisal guidance
  • TA223
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that naftidrofuryl oxalate is recommended as an option for treating people with intermittent claudication who have peripheral arterial disease.

ISBN: 978-1-4731-6674-5